- Home
- CELC vs MBAV Comparison
CELC vs MBAV Comparison
Compare CELC & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- MBAV
- Stock Information
- Founded
- CELC 2011
- MBAV 2024
- Country
- CELC United States
- MBAV United States
- Employees
- CELC N/A
- MBAV N/A
- Industry
- CELC Medical Specialities
- MBAV
- Sector
- CELC Health Care
- MBAV
- Exchange
- CELC Nasdaq
- MBAV NYSE
- Market Cap
- CELC 327.3M
- MBAV 368.4M
- IPO Year
- CELC 2017
- MBAV 2024
- Fundamental
- Price
- CELC $10.24
- MBAV $10.23
- Analyst Decision
- CELC Strong Buy
- MBAV
- Analyst Count
- CELC 6
- MBAV 0
- Target Price
- CELC $30.17
- MBAV N/A
- AVG Volume (30 Days)
- CELC 392.7K
- MBAV 13.1K
- Earning Date
- CELC 05-14-2025
- MBAV 01-01-0001
- Dividend Yield
- CELC N/A
- MBAV N/A
- EPS Growth
- CELC N/A
- MBAV N/A
- EPS
- CELC N/A
- MBAV 0.24
- Revenue
- CELC N/A
- MBAV N/A
- Revenue This Year
- CELC N/A
- MBAV N/A
- Revenue Next Year
- CELC N/A
- MBAV N/A
- P/E Ratio
- CELC N/A
- MBAV $43.06
- Revenue Growth
- CELC N/A
- MBAV N/A
- 52 Week Low
- CELC $7.58
- MBAV $9.97
- 52 Week High
- CELC $19.77
- MBAV $10.53
- Technical
- Relative Strength Index (RSI)
- CELC 54.38
- MBAV N/A
- Support Level
- CELC $7.58
- MBAV N/A
- Resistance Level
- CELC $10.48
- MBAV N/A
- Average True Range (ATR)
- CELC 1.04
- MBAV 0.00
- MACD
- CELC 0.17
- MBAV 0.00
- Stochastic Oscillator
- CELC 80.01
- MBAV 0.00
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About MBAV M3-BRIGADE ACQUISITION V CORP
M3-Brigade Acquisition V Corp is a blank check company.